| Issue Date | Title | Author(s) |
| 2020-08-24 | Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems | Dua, K; Hansbro, PM; Wadhwa, R; Haghi, M; Pont, LG; Williams, KA |
| 2020-04-20 | Role of Oxidative Stress in Complexity of Respiratory Diseases | Ghadiri, M; Yung, AE; Haghi, M; Maurya, P; Dua, K |
| 2020-01 | Pharmacologic Inhibition of Vacuolar H+ATPase Attenuates Features of Severe Asthma in Mice. | McAlinden, KD; Kota, A; Haghi, M; Ghavami, S; Sharma, P |
| 2020-11-16 | Advancing of Cellular Signaling Pathways in Respiratory Diseases Using Nanocarrier based Drug Delivery Systems. | Mehta, M; Dhanjal, DS; Satija, S; Wadhwa, R; Paudel, KR; Chellappan, DK; Mohammad, S; Haghi, M; Hansbro, PM; Dua, K |
| 2021-01 | Manipulation of the Upper Respiratory Microbiota to Reduce Incidence and Severity of Upper Respiratory Viral Infections: A Literature Review. | Nesbitt, H; Burke, C; Haghi, M |
| 2022-03-24 | Biologics and Vaccines for Nasal and Pulmonary Drug Delivery | Komalla, V; Haghi, M; Kayser, V |
| 2021-06-23 | Current practice in cancer pharmacotherapy | Pont, L; Dua, K; Cutler, RL; Benson, H; Haghi, M; Cardenas, VG; Smit, CCH; Ao, A; Williams, KA |
| 2021 | The Potential for Phospholipids in the Treatment of Airway Inflammation: An Unexplored Solution. | Komalla, V; Mehta, M; Achi, F; Dua, K; Haghi, M |
| 2022-04-01 | Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate | Sheikholeslami, B; Lam, NW; Dua, K; Haghi, M |
| 2022-08 | Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases. | Chan, Y; Singh, SK; Gulati, M; Wadhwa, S; Prasher, P; Kumar, D; Kumar, AP; Gupta, G; Kuppusamy, G; Haghi, M; George Oliver, BG; Adams, J; Chellappan, DK; Dua, K |
